ANNX (ANNX) Stock Price & Analysis
ANNX (ANNX) fell 2.98% to USD 4.73 as of September 8, 2026 at 14:52 UTC, according to Nexqual real-time market data.
ANNX last closed at USD 4.73; the session ranged USD 4.68–4.78 on volume of 401,916 shares. Market capitalization is —, with a 52-week range of USD 2.1–7.18 (NMS). Source: Nexqual, September 8, 2026 at 14:52 UTC.
Key Statistics (as of September 8, 2026 at 14:52 UTC)
| Price | USD 4.73 |
|---|---|
| Change | ▼ 2.98% (down) |
| Previous Close | USD 4.73 |
| Open | USD 4.73 |
| Day Range | USD 4.68 – 4.78 |
| 52-Week Range | USD 2.1 – 7.18 |
| Volume | 401,916 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (ANNX)
Nexqual's technical model rates ANNX "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of September 8, 2026 at 14:52 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 38.79 (neutral) |
| vs SMA50 | Below (USD 5.36) |
| MACD | -0.14 (negative) |
From ANNX's Latest SEC 10-K Filing (filed 2026-03-30)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ALXO | ALX Oncology Holdings Inc. | USD 2.01 | ▼ 1.23% |
| FDMT | 4D Molecular Therapeutics, Inc. | USD 15.16 | ▲ 3.13% |
| NKTX | Nkarta, Inc. | USD 2.93 | ▲ 4.84% |
| CCCC | C4 Therapeutics, Inc. | USD 3.67 | ▼ 1.93% |
| ORIC | Oric Pharmaceuticals, Inc. | USD 12.83 | ▲ 0.71% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 14:52 UTC. This page is informational and not investment advice.